Alcura France has accepted an irrevocable offer from Santé Cie Group to sell its home healthcare operations, facilitating a strategic focus on core service areas.
Information on the Target
Alcura France, a wholly owned subsidiary of Mutares SE & Co. KGaA, has received an irrevocable offer to divest its Care Services division, specifically focusing on home healthcare known as PSAD (Prestations de Santé à Domicile). This division generated approximately EUR 17 million in revenue in France during 2024. The acquisition is poised to enhance the efficiency and focus of Alcura France by divesting non-core operations while allowing the company to concentrate on its primary care services.
The buyer, Santé Cie Group, is recognized as a leading European provider of home and outpatient care services. This acquisition reflects the strategic importance of home healthcare, which has seen an increasing demand due to demographic changes and a growing preference for at-home care solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The home healthcare industry in France is undergoing significant transformation, driven by an aging population and advancements in medical technology. With an increasing number of individuals opting for home care services as a
Similar Deals
GENEO Capital Entrepreneur → Seiven
2025
Vesper Next Generation Infrastructure Fund I SCSp and Infracapital → SAF Aerogroup
2025
Eurazeo, Crédit Mutuel Equity, Bpifrance, BNP Paribas Développement → Proteor
2025
IMDEV → centre d'Imagerie Médicale Saint-Claude
2024
Santé Cie Group
invested in
Alcura France
in 2025
in a Other Private Equity deal
Disclosed details
Revenue: $19M